enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Oclacitinib - Wikipedia

   en.wikipedia.org/wiki/Oclacitinib

   Oclacitinib, sold under the brand name Apoquel among others, is a veterinary medication used in the control of atopic dermatitis and pruritus from allergic dermatitis in dogs at least 12 months of age. [1] [4] Chemically, it is a synthetic cyclohexylamino pyrrolopyrimidine janus kinase inhibitor that is relatively selective for JAK1. [5]

3. FDA Approves APOQUEL® (oclacitinib tablet) to Control Itch ...

   www.aol.com/news/2013-05-16-fda-approves-apoquel...

   APOQUEL should not be used in breeding dogs, or pregnant or lactating dogs. The most common side effects seen in dogs administered APOQUEL were vomiting and diarrhea. APOQUEL has been safely used ...

4. List of veterinary drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_veterinary_drugs

   amitriptyline – tricyclic antidepressant used to treat separation anxiety, excessive grooming dogs and cats; amlodipine – calcium channel blocker used to decrease blood pressure; amoxicillin – antibacterial; apomorphine – emetic (used to induce vomiting) artificial tears – lubricant eye drops used as a tear supplement

5. Apoquel for Cats: Uses, Dosage, & Side Effects - AOL

   www.aol.com/lifestyle/apoquel-cats-uses-dosage...

   Apoquel is a medication prescribed for pets — particularly dogs — to alleviate symptoms associated with allergic dermatitis, such as itching and inflammation. The FDA has not officially ...

6. US FDA approves Elanco's skin disease treatment for dogs - AOL

   www.aol.com/news/us-fda-approves-elancos-skin...

   By Sriparna Roy (Reuters) -The U.S. Food and Drug Administration has approved Elanco Animal Health's skin disease treatment for dogs, the health regulator's website showed on Thursday, sending the ...

7. Lokivetmab - Wikipedia

   en.wikipedia.org/wiki/Lokivetmab

   Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs. [1] It acts against interleukin 31 (IL-31), [2] which is a cytokine involved in causing itchiness (pruritus). [2] Lokivetmab is administered by subcutaneous injection; each dose is effective for four to eight weeks. [3]